Stay updated on Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous v3.6.1 as the study document version. This appears to be an administrative update that does not modify core study content.
    Difference
    0.0%
    Check dated 2026-07-02T02:31:40.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.1, signaling a small build update. The study content and visible information remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-24T23:18:36.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The study record now shows recruitment is closed to new participants, and new recruitment sites (e.g., Hunan Cancer hospital 1 and University College Hospital) along with updated navigation items were added to aid readers in understanding how to join and read the study.
    Difference
    0.3%
    Check dated 2026-06-10T14:41:35.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a new version of the study documentation has been issued for the record.
    Difference
    0.0%
    Check dated 2026-06-03T08:10:18.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new revision entry was added: Revision: v3.5.4, replacing the prior v3.5.3. This indicates a routine update to the Study Details page.
    Difference
    0.0%
    Check dated 2026-05-19T23:57:58.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The update history now includes May 2026 entries (2026-05-08, 2026-05-07, 2026-05), while April 2026 entries (2026-04-22, 2026-04-09, 2026-04) were removed. These entries document when the page was updated, not changes to the study content.
    Difference
    0.1%
    Check dated 2026-05-12T20:51:56.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.